CMChin Yu Mok

Chin Yu Mok

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chin Yu Mok has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Deciphering the initiation pathway of CagT4SS assembly by in vitro reconstitution of subcomplexes

    by Hoi Yee Chu, Chin Yu Mok, You-Rong Lin, Huawei Zhang, Takayuki Uchihashi, Shannon Wing Ngor Au

    Cag type IV secretion system (CagT4SS) mediates the translocation of diverse substrates and is critical for the Helicobacter pylori pathogenesis. Its assembly is initiated by the central cylinder comprising CagX, CagY and CagM, however, the order and detailed mechanism remain unclear. Here, we characterize their respective self-oligomerizing properties and in vitro reconstitute subcomplexes that recapitulate features of the native nanomachine. By integrating multiple biophysical analyses, the structures, binding kinetics and conformational dynamics of assembly intermediates are shown. The assembly begins with self-oligomerization of CagX, followed by CagY association to form a stable periplasmic ring complex (PRC). CagM is subsequently coupled with CagX through multimerization of dimers, with CagY enhancing both the stability and cooperativity of its association. Our findings show the spatial and temporal nature of the assembly process, in particular the significance of PRC substructure, providing mechanistic insights into the biogenesis of bacterial T4SSs beyond static models.


  • Open Access

    Structures of Helicobacter pylori C-terminal protease CtpA reveal a new mode of self-contained proteolytic processing

    by Kailei Sun, Lili Yan, Chin Yu Mok, Pui Kin So, Sirius Pui Kam Tse, Kwok Fai Lau, Daping Wang, Huawei Zhang, Shannon Wing Ngor Au

    Bacterial carboxyl-terminal processing proteases (CTPs) are essential for protein quality control, signal transduction, and cell adaptation. Typically, activation of CTPs involves substrate binding to the PDZ domain or an adaptor protein. Recent studies of CTPs from various bacterial species have indicated structural diversity in CTP oligomerisation. However, the activation mechanisms and rationale for these different oligomeric forms are not well characterised or understood. Here, we present biophysical analyses of CtpA from Helicobacter pylori , which assembles into a trimer-of-dimer (hexameric) configuration. Hydrogen–deuterium exchange mass spectrometry shows that CtpA transitions between resting and active states independently of substrate binding. Cryo-electron microscopy and crystal structural analysis of CtpA further reveal that only one subunit per dimer is active at a time, driven by asymmetric conformational changes. This asymmetric activation supports a cooperative mechanism in which hexameric subunits synchronise to regulate proteolytic activity. Coordinated inter-subunit interactions and concerted movements of the PDZ domain and motile loop generate three self-compartmentalised catalytic units that enable processive substrate degradation. We also identify intra- and intermolecular interactions that stabilise functional states, allowing adaptor-independent activation. These findings open a new avenue towards understanding the key elements of oligomeric assembly in protease activation.


  • Open Access

    Tetrandrine regulates NAADP-mediated calcium signaling through a LIMP-2-dependent and sphingosine-mediated mechanism

    by Wing-Cheung Chan, Qian Zhao, Koon Ho Wong, Hok-Him Tang, Daniel Kam-Wah Mok, Lakhansing Pardeshi, Ye Chun Ruan, Yang Yang, Chi-Ming Wong, Clarence T. T. Wong, et al.

    Tetrandrine (Tet) is a potent inhibitor of Ebola virus replication by blocking NAADP-dependent calcium release through endolysosomal two-pore channels (TPCs) and a moderately potent anti-tumor agent. Using a clickable photoaffinity probe, we identify lysosomal integral membrane protein-2 (LIMP-2) as a direct target of Tet and a key regulator of this calcium signaling. Tet binds LIMP-2’s ectodomain, inhibiting lysosomal cholesterol and sphingosine transport, which alters lipid metabolism. Tet treatment and LIMP-2 depletion inhibit NAADP-dependent calcium release, reversible by removing lysosomal cholesterol and sphingosine. Sphingosine triggers lysosomal calcium release via TPCs and restores this signaling in Tet-treated or LIMP-2-deficient cells, revealing a LIMP-2-regulated, sphingosine-dependent lysosomal calcium pathway. At higher doses, Tet induces apoptosis through unfolded protein response activation independently of LIMP-2. These findings highlight Tet as a LIMP-2 inhibitor, elucidate its role in calcium signaling and cell death, and suggest therapeutic potential for Tet and LIMP-2 inhibitors in antiviral treatments.